A Registry of Biospecimens at Mayo Clinic to Support Translational Research into the Biology, Etiology and Prognosis of Neuroendocrine Tumors

Overview

About this study

The purpose of this registry at Mayo Clinic Jacksonville, is to keep a database and biospecimens of all patients treated surgically and non-surgically for a gastro-enteropancreatic mass or a suspected metastatic lesion from a gastro-entero-pancreatic primary. This registry will keep demographic, clinical and pathologic data on each patient as well as follow-up information on outcome endpoints such as death and recurrence of disease, blood cell samples, and tissue samples from surgically removed tumors.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • 18 years of age or older
  • Has a gastro-enteropancreatic mass or a suspected metastatic lesion from a gastro-enteropancreatic primary that is treated surgically or non-surgically is eligible to participate in the study 
  • Must be capable of and willing to sign an informed consent

Exclusion Criteria

  •  Does not meet inclusion criteria

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Ana-Maria Chindris, M.D.

Closed for enrollment

Contact information:

Ana-Maria Chindris M.D.

(904) 953-2381

Chindris.AnaMaria@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20359594

Mayo Clinic Footer